J2277 HCPCS Level II code: Injection, motixafortide, 0.25 mg
J2277 is the HCPCS code for “Injection, motixafortide, 0.25 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2277Injection, motixafortide, 0.25 mg
Short description: Inj, motixafortide, 0.25 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J2277 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Apr 1, 2024
Where J2277 sits
- 1J codesDrugs administered other than orally
- 2Active code J2277Injection, motixafortide, 0.25 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2277 mean?
J2277 is the HCPCS code for “Injection, motixafortide, 0.25 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2277?
CMS lists J2277’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2277
All J codesJ2267Injection, mirikizumab-mrkz, 1 mgJ2270Injection, morphine sulfate, up to 10 mgJ2271Injection, morphine sulfate, 100mgJ2272Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mgJ2274Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mgJ2275Injection, morphine sulfate (preservative-free sterile solution), per 10 mgJ2278Injection, ziconotide, 1 microgramJ2280Injection, moxifloxacin, 100 mgJ2281Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mgJ2290Injection, nafcillin sodium, 20 mgJ2291Injection, nafcillin sodium (baxter), 20 mgJ2300Injection, nalbuphine hydrochloride, per 10 mg